Clinical Trial Update: Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage [Phase 4]

View source ↗

Summary

Phase IV pharmacokinetic study comparing topically applied Veregen 15% with oral green tea intake to assess systemic exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Warts
• Perianal Warts

Drugs mentioned

• Veregen 15% topical ointment (sinecatechin)

Snippet

Sponsor: MediGene | Conditions: Genital Warts, Perianal Warts | Phase 4 | Status: COMPLETED